AWM
TNYA icon

Avior Wealth Management’s Tenaya Therapeutics TNYA Stock Holding History

Avior Wealth Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.68K Hold
13,100
– – ﹤0.01% 786
2026
Q1 		$9.07K Buy
+13,100
New +$9.67K ﹤0.01% 824
2024
Q2 		– Sell
-11
Closed -$57 – 3606
2024
Q1 		$57 Buy
+11
New +$53 ﹤0.01% 3425

Other funds holding TNYA

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Avior Wealth Management's TNYA Position: Q2 2026 in Review

Avior Wealth Management held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 13,100 shares worth $9.68K. The position accounts for ﹤0.01% of the portfolio, ranked #786.

Avior Wealth Management first reported a position in TNYA in Q1 2024 and has held it in 3 quarters since. 9 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Avior Wealth Management held 13,100 shares of Tenaya Therapeutics worth $9.68K as of Q2 2026.
  • Avior Wealth Management left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Avior Wealth Management's portfolio in Q2 2026, its #786 holding.
  • Avior Wealth Management first reported a position in Tenaya Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 9 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.